AN1

0.00%

0.8¢ anagenics limited

Maria Halasz Share Price Tracker, page-30

First 30 Last

Share
Profile

Follow
Taurean7

1,773 Posts.

3106

06/03/15

23:10

Post #: 14875481
Share

Originally posted by Ooogerbooger ↑

I asked her about a timeline for the midkine antibody program. While I did not ask her if I could release the details, I don't see any problem with posting an excerpt:
"With the funds raised we will be able to progress to a pre-IND meeting by completing (human in vitro) tissue cross reactivity and single dose toxicity studies (page 1 of our newsletter). These are significant milestones and go towards de-risking the program. As you point out toxicity is one of the areas we need to address and these will be the first ever formal toxicology studies of our antibody.

We have released the approximate timing of the pre-IND meeting as mid 2015 although it will depend on many factors, some outside of our control, like the FDA. On the other hand, the timing of the clinical trials will depend on availability of funding, manufacturing timetables, clinical facilities etc. Hence it is not possible to commit to a timeline at this stage on this front. "

Overall, the email gave the impression of competence and it was not formulaic. She scored brownie points with me for it.

I'm anticipating shrill cries of derision on this forum in response to this post. I'm not proposing to respond to them or to engage in further correspondence on HC about this or any other matters. For many months I have followed the HC forums without registering or posting. I am going to revert to that policy, because there is way too much name-calling and emoting here and the moderation is used like a blunt instrument. Cheers.

Expand

Thanks for the information Oooger. Sorry to see you go. The forum could only benefit from more of your rational commentary.

Cheers

CDY Price at posting: 2.4¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

HLX

Helix investor makes partial takeover bid, proposing board changes

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

There are more pages in this discussion • 4 more messages in this thread...

First 30 Last

Add AN1 (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $3.690M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	1091271	0.7¢

Sellers (Offers)

Price($)	Vol.	No.
0.8¢	656147	1

View Market Depth

No.	Vol.	Price($)
1	1091271	0.007
3	565639	0.006
1	300000	0.005
3	825000	0.004
1	600000	0.003

Price($)	Vol.	No.
0.008	656147	1
0.009	80000	1
0.010	157763	1
0.015	340000	2
0.016	100000	1

Last trade - 16.12pm 30/08/2024 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

Maria Halasz Share Price Tracker, page-30

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Helix investor makes partial takeover bid, proposing board changes

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

The Calmer Co’s Anthony Noble reflects on record breaking FY24

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Lendlease sells off US east coast construction operations in latest global divestment push

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Maria Halasz Share Price Tracker, page-30

Top Stories

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Helix investor makes partial takeover bid, proposing board changes

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

The Calmer Co’s Anthony Noble reflects on record breaking FY24

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Lendlease sells off US east coast construction operations in latest global divestment push

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News